9th Apr 2015 17:51
For filings with the FCA include the annex | |||||||||||||||||
For filings with issuer exclude the annex | |||||||||||||||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i | |||||||||||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Allergy Therapeutics PLC | ||||||||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||||||||||||||
An acquisition or disposal of voting rights | X | ||||||||||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||||||||||||||
An event changing the breakdown of voting rights | |||||||||||||||||
Other (please specify): |
| ||||||||||||||||
3. Full name of person(s) subject to the notification obligation: iii | SOUTHERN FOX INVESTMENTS LTD. | ||||||||||||||||
4. Full name of shareholder(s) (if different from 3.): iv | CHASE NOMINEES LTD - CMBLJPPB | ||||||||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: v | 1st April, 2015 | ||||||||||||||||
6. Date on which issuer notified: | 9th April, 2015 | ||||||||||||||||
7. Threshold(s) that is/are crossed or reached: vi, vii | Over 22.93% | ||||||||||||||||
8. Notified details: | |||||||||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||||||||
Ord GBP 0.01 GB00B02LCQ05 | 111,589,283 | 111,589,283 | 125,183,783 | 125,183,783 | 22.93% | ||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/ConversionPeriod xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted.
| % of votingrights | |||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Exerciseprice | Expirationdate xvii | Exercise/Conversionperiod xviii | Number of votingrights instrumentrefers to | % of voting rights xix, xx
| ||||||||||||
Nominal | Delta
| ||||||||||||||||
Total (A+B+C) | |||||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||||
125,183,783 | 22.93% | ||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | |||||||||||||||||
| |||||||||||||||||
Proxy Voting: | |||||||||||||||||
10. Name of the proxy holder: | SOUTHERN FOX INVESTMENTS LTD | ||||||||||||||||
11. Number of voting rights proxy holder will cease to hold: | |||||||||||||||||
12. Date on which proxy holder will cease to hold voting rights: | |||||||||||||||||
13. Additional information: | |||||||||||||||||
14. Contact name: | George O'Carroll | ||||||||||||||||
15. Contact telephone number: | +353-61-472019 | ||||||||||||||||
Related Shares:
Allergy Thera.